Stockreport

Revance slips 6% on Allergan takeout of Bonti [Seeking Alpha]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Revance Therapeutics ( RVNC ) is down on light volume in early trade on the heels of Allergan's announced acquisition of Bonti, a developer of fast-acting neurot [Read more]